Mots-c
40mg
140.00$
Mots-c is studied for its role in cellular energy regulation and metabolic balance. Researchers are interested in how this peptide may influence how cells use fuel, respond to metabolic stress, and maintain energy efficiency over time.
Mots-c
Product Name: Mots-c
Type: Mitochondrial Research Peptide
Research Focus:
MOTS-c is a 16–amino-acid mitochondrial-derived peptide (MDP) that acts as a metabolic regulator, primarily through AMPK activation[1][2]. Preclinical studies show it enhances insulin sensitivity, promotes fat oxidation, improves exercise capacity, and counters age-related metabolic decline[1][4]. No clinical trials have been completed in humans to date[8]. This educational protocol presents a once-daily subcutaneous approach with gradual titration.
Reconstitution:
Reconstitute: Add 3.0 mLbacteriostatic water → ~6.67 mg/mLconcentration.
Typical daily range: 200–1,000 mcgonce daily (gradual titration over 10 weeks).
Easy measuring: At 6.67 mg/mL, 1 unit = 0.01 mL ≈ 66.7 mcg on a U‑100 insulin syringe.
Storage: Lyophilized: freeze at −20 °C (−4 °F) or below; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F)and use within 7 days for best potency.
Research Interest:
Energy utilization and metabolic efficiency models
Cellular stress and resilience research
Metabolic signaling linked to aging pathways
Glucose and insulin-related pathway studies
Scientific Interest:
Mitochondrial communication with the cell nucleus
Energy balance signaling networks
Cellular adaptation to metabolic demand
Cycle:
Standard / Gradual Approach (3 mL = ~6.67 mg/mL)
WEEK | DAILY DOSE (MCG) | UNITS (PER INJECTION) (ML) |
|---|---|---|
Weeks 1–2 | 200 mcg (0.2 mg) | 3 units (0.03 mL) |
Weeks 3–4 | 400 mcg (0.4 mg) | 6 units (0.06 mL) |
Weeks 5–6 | 600 mcg (0.6 mg) | 9 units (0.09 mL) |
Weeks 7–8 | 800 mcg (0.8 mg) | 12 units (0.12 mL) |
Weeks 9–10+ | 1,000 mcg (1.0 mg) | 15 units (0.15 mL) |
Frequency: Inject once dailysubcutaneously[7]. Stay at each dose level for approximately 2 weeks before increasing, and monitor for any adverse reactions[7].
For ≤10‑unit (≤0.10 mL) administrations, consider 30‑ or 50‑unit insulin syringes for improved readability.
Reconstitution Steps
Draw 3.0 mL bacteriostatic water with a sterile syringe.
Inject slowly down the vial wall; avoid foaming.
Gently swirl/roll until dissolved (do not shake vigorously).
Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
Use within 7 days for optimal potency[7].
IMPORTANT NOTICE:
This product is intended strictly for laboratory research. It is not intended to diagnose, treat, cure, or prevent any disease.
King St. West,
Toronto, Ontario
Canada.
M6K 3M3